Synergy Pharmaceuticals Shares Outstanding 2007-2018 | SGYP

Synergy Pharmaceuticals shares outstanding from 2007 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Synergy Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2017 225
2016 164
2015 106
2014 94
2013 85
2012 62
2011 48
2010 45
2009 37
2008 59
2007 83
2006 83
Synergy Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 248
Q2 2018 247
Q1 2018 247
Q4 2017 225
Q3 2017 225
Q2 2017 225
Q1 2017 215
Q4 2016 164
Q3 2016 180
Q2 2016 168
Q1 2016 118
Q4 2015 106
Q3 2015 111
Q2 2015 100
Q1 2015 97
Q4 2014 94
Q3 2014 95
Q2 2014 94
Q1 2014 92
Q4 2013 85
Q3 2013 90
Q2 2013 87
Q1 2013 73
Q4 2012 62
Q3 2012 66
Q2 2012 60
Q1 2012 54
Q4 2011 48
Q3 2011 47
Q2 2011 47
Q1 2011 46
Q4 2010 45
Q3 2010 45
Q2 2010 44
Q1 2010 44
Q4 2009 37
Q3 2009 38
Q2 2009 34
Q1 2009 33
Q4 2008 59
Q3 2008 40
Q2 2008 83
Q1 2008 83
Q4 2007 83
Q3 2007 83
Q2 2007 30
Q1 2007 1
Q4 2006 83
Q3 2006 1
Q2 2006 1
Q1 2006 1
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.059B $0.017B
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. Its lead drug candidate plecanatide is a guanylyl cyclase C receptor agonist, to treat GI disorders, primarily chronic constipation and constipation-predominant- irritable bowel syndrome. It is also engaged in developing receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis. Synergy Pharmaceuticals, Inc. is headquartered in New York, New York.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $39.978B 27.37
Takeda Pharmaceutical (TAK) Japan $30.466B 14.23
Grifols (GRFS) Spain $13.119B 15.90
Neurocrine Biosciences (NBIX) United States $7.978B 1759.60
Tilray (TLRY) United States $7.976B 0.00
Ionis Pharmaceuticals (IONS) United States $7.866B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.731B 11.10
Nektar Therapeutics (NKTR) United States $7.723B 11.07
Loxo Oncology (LOXO) United States $7.141B 0.00
Sage Therapeutics (SAGE) United States $6.358B 0.00
Catalent (CTLT) United States $5.034B 21.12
United Therapeutics (UTHR) United States $4.952B 8.10
FibroGen (FGEN) United States $4.306B 0.00
TESARO (TSRO) United States $4.122B 0.00
Impax Laboratories (AMRX) United States $3.711B 19.73
Taro Pharmaceutical Industries (TARO) Israel $3.612B 13.37
USANA Health Sciences (USNA) United States $2.805B 23.88
Endo (ENDP) Ireland $2.167B 3.32
Heron Therapeutics (HRTX) United States $2.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.064B 0.00
Xencor (XNCR) United States $1.944B 0.00
Aerie Pharmaceuticals (AERI) United States $1.916B 0.00
Corcept Therapeutics (CORT) United States $1.784B 26.19
Zogenix (ZGNX) United States $1.761B 0.00
PTC Therapeutics (PTCT) United States $1.759B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.739B 0.00
Portola Pharmaceuticals (PTLA) United States $1.696B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.576B 213.00
Theravance Biopharma (TBPH) Cayman Islands $1.476B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.429B 20.11
Arrowhead Pharmaceuticals (ARWR) United States $1.338B 0.00
TherapeuticsMD (TXMD) United States $1.232B 0.00
Esperion Therapeutics (ESPR) United States $1.153B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.119B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.011B 0.00
Tricida (TCDA) United States $0.952B 0.00
Radius Health (RDUS) United States $0.747B 0.00
ImmunoGen (IMGN) United States $0.744B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.624B 0.00
ChemoCentryx (CCXI) United States $0.617B 48.88
Karyopharm Therapeutics (KPTI) United States $0.597B 0.00
Siga Technologies (SIGA) United States $0.597B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.566B 0.00
Collegium Pharmaceutical (COLL) United States $0.528B 0.00
Flexion Therapeutics (FLXN) United States $0.507B 0.00
Forty Seven (FTSV) United States $0.493B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.468B 27.58
GlycoMimetics (GLYC) United States $0.461B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.450B 0.00
Odonate Therapeutics (ODT) United States $0.441B 0.00
ArQule (ARQL) United States $0.416B 0.00
Tyme Technologies (TYME) United States $0.361B 0.00
CASI Pharmaceuticals (CASI) United States $0.359B 0.00
Xeris Pharmaceuticals (XERS) United States $0.358B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.357B 0.00
Akebia Therapeutics (AKBA) United States $0.353B 0.00
Majesco Entertainment (PTE) United States $0.349B 0.00
Concert Pharmaceuticals (CNCE) United States $0.327B 0.00
KalVista Pharmaceuticals (KALV) United States $0.326B 0.00
OptiNose (OPTN) United States $0.305B 0.00
Lannett Co Inc (LCI) United States $0.296B 2.56
Dermira (DERM) United States $0.282B 0.00
Minerva Neurosciences (NERV) United States $0.280B 0.00
Depomed (ASRT) United States $0.270B 10.05
Verrica Pharmaceuticals (VRCA) United States $0.269B 0.00
Tapimmune (MRKR) United States $0.268B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.266B 0.00
Aclaris Therapeutics (ACRS) United States $0.264B 0.00
Mast Therapeutics (SVRA) United States $0.260B 0.00
IMV INC (IMV) Canada $0.259B 0.00
Translate Bio (TBIO) United States $0.255B 0.00
Aldeyra Therapeutics (ALDX) United States $0.235B 0.00
Opexa Therapeutics (ACER) United States $0.232B 0.00
Dova Pharmaceuticals (DOVA) United States $0.226B 0.00
Affimed (AFMD) Germany $0.224B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.210B 0.00
MEI Pharma (MEIP) United States $0.201B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.201B 0.00
Aratana Therapeutics (PETX) United States $0.199B 0.00
Galectin Therapeutics (GALT) United States $0.194B 0.00
Aquestive Therapeutics (AQST) United States $0.191B 0.00
Zafgen (ZFGN) United States $0.174B 0.00
Molecular Templates (MTEM) United States $0.174B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.172B 0.00
Recro Pharma (REPH) United States $0.168B 0.00
Calithera Biosciences (CALA) United States $0.167B 0.00
Ocular Therapeutix (OCUL) United States $0.163B 0.00
Jounce Therapeutics (JNCE) United States $0.160B 0.00
Rafael Holdings (RFL) United States $0.160B 0.00
Nature's Sunshine Products (NATR) United States $0.152B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.152B 0.00
Redhill Biopharma (RDHL) Israel $0.148B 0.00
Neon Therapeutics (NTGN) United States $0.146B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.145B 0.00
Adherex Technologies (FENC) United States $0.142B 0.00
Ardelyx (ARDX) United States $0.139B 0.00
ElectroCore (ECOR) United States $0.138B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.137B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.135B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.124B 0.00
MediWound (MDWD) Israel $0.122B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.119B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.114B 0.00
Champions Oncology (CSBR) United States $0.109B 0.00
DURECT (DRRX) United States $0.102B 0.00
ProNAi Therapeutics (SRRA) Canada $0.100B 0.00
Aptorum Group (APM) China $0.099B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.095B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.093B 0.00
Natural Alternatives (NAII) United States $0.083B 8.15
Iterum Therapeutics (ITRM) Ireland $0.082B 0.00
Cardiome Pharma (CORV) Canada $0.081B 0.00
Nivalis Therapeutics (ALPN) United States $0.080B 0.00
Infinity Pharmaceuticals (INFI) United States $0.076B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.076B 0.00
CTI BioPharma (CTIC) United States $0.074B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.072B 0.00
KemPharm (KMPH) United States $0.070B 0.00
Avenue Therapeutics (ATXI) United States $0.068B 0.00
Immune Design (IMDZ) United States $0.067B 0.00
Neos Therapeutics (NEOS) United States $0.065B 0.00
BioLineRx (BLRX) Israel $0.065B 0.00
Otonomy (OTIC) United States $0.062B 0.00
Achaogen (AKAO) United States $0.061B 0.00
Melinta Therapeutics (MLNT) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.053B 0.00
Genocea Biosciences (GNCA) United States $0.053B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
ContraFect (CFRX) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.046B 0.00
Novan (NOVN) United States $0.041B 0.00
Capnia (SLNO) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Lipocine (LPCN) United States $0.034B 0.00
Heat Biologics (HTBX) United States $0.031B 0.00
PharmAthene (ALT) United States $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.025B 0.00
ESSA Pharma (EPIX) Canada $0.025B 0.00
Trillium Therapeutics (TRIL) Canada $0.024B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Biomerica (BMRA) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
Aviragen Therapeutics (VXRT) United States $0.016B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.015B 0.00
Shineco (TYHT) China $0.013B 1.45
Onconova Therapeutics (ONTX) United States $0.012B 0.00
Skyline Medical (AIPT) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00